EssilorLuxottica stock gains as buyback program supports valuation
Published on 08/31/2026 at 08:04 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
EssilorLuxottica (ISIN FR0000033219) stock is drawing renewed investor interest on August 31, 2026 as the group launches a share buyback program while the shares trade above EUR 160 on Euronext Paris.
The buyback announcement underlines management’s confidence in long-term value creation at a time when the company’s market capitalization has fallen to about EUR 75 billion in 2026 after a drop of 40 percent in the share price earlier in the year.
For investors, the combination of active capital returns and a still sizable equity value makes the current trading levels a key reference point in the broader eyewear and vision-care sector.
Buyback program backs the share price
On August 31, 2026 EssilorLuxottica said it was launching a new share repurchase program that covers up to 5 million shares, adding direct support to the stock in the market. A detailed report on the buyback plan explains that this move is intended to reflect confidence in the company’s ability to create value over the long run.
The announced size of the buyback represents a meaningful portion of the free float when set against a market capitalization around EUR 75 billion in 2026, a figure that has been depressed by a year-to-date share price decline of 40 percent cited in recent coverage.
In practical terms, retiring up to 5 million shares can improve per-share metrics over time and may help absorb selling pressure as investors reassess the risk-reward after the earlier drawdown.
Shares rebound above EUR 160
Market data for late August 2026 shows EssilorLuxottica stock trading above EUR 160 on Euronext Paris, with one quote snapshot indicating a level of EUR 161.35 along with an intraday gain of EUR 10.75 or 2.40 percent for that session. A European market overview lists EssilorLuxottica in its price table and highlights this move.
That price around EUR 161 is still well below the level implied by the stock’s value of $158.42 at the start of 2026 on the US over-the-counter line, where the shares most recently changed hands at $93.72 on August 28, 2026. A detailed ESLOY quote snapshot notes that the US-traded line has fallen 40.8 percent since January 1, 2026.
The quantified comparison between the January 1, 2026 US price of $158.42 and the August 28, 2026 level of $93.72 underscores how much value has been lost year-to-date, even though the European quote above EUR 160 signals some recovery from the trough.
Valuation and sector context
The share price decline has had a direct impact on EssilorLuxottica’s valuation, with recent reporting stating that the group’s equity value now stands near EUR 75 billion in 2026, versus a significantly higher level before the downturn.
At a price point in the EUR 160 area and a market capitalization around EUR 75 billion, investors are effectively paying a lower multiple for the company’s portfolio of eyewear brands and optical technologies than in prior years when the stock traded at higher levels.
The fresh buyback authorization reinforces that management views the current valuation as attractive, and for shareholders the numerical gap between the early-2026 US price of $158.42 and today’s $93.72 level provides a concrete measure of potential upside should fundamentals and sentiment improve.
Ray-Ban and premium eyewear franchise
EssilorLuxottica’s investment case is closely tied to its global brand portfolio, including flagship labels such as Ray-Ban that anchor the company’s premium positioning in sunglasses and eyewear.
Recent coverage has highlighted a broader narrative around the Ray-Ban franchise and a reported $65 billion fortune associated with that brand, illustrating the scale of value tied to EssilorLuxottica’s heritage and intellectual property.
For consumers, Ray-Ban remains one of the most recognizable names in sunglasses, and for investors the continued strength of this and other house brands supports long-term revenue potential even through periods of share-price volatility.
EssilorLuxottica products in everyday use
Beyond the stock market, EssilorLuxottica’s products span corrective lenses, sunglasses, frames, and related optical solutions that millions of people use daily.
Ray-Ban sunglasses, for example, blend fashion and function by combining lens technology with distinctive frame designs, making them a representative consumer product in the group’s portfolio.
The company’s ability to sustain demand for such premium products is an important element in the long-term story that sits behind the current valuation and the decision to deploy capital through buybacks.
Shares and recent price levels
EssilorLuxottica stock is listed on Euronext Paris, and as of the most recent late-August 2026 quotation the shares traded at EUR 161.35 during a session that saw an increase of EUR 10.75 or 2.40 percent.
On the US over-the-counter market, the ESLOY line most recently closed at $93.72 on August 28, 2026, reflecting the 40.8 percent decline from the January 1, 2026 level of $158.42 that has shaped the year’s performance profile.
These dated figures provide investors with concrete reference points for assessing EssilorLuxottica’s market trajectory in 2026 alongside the announced buyback program and the company’s underlying brand strength.
Read more
More on EssilorLuxottica stock
Fact box
Company: EssilorLuxottica S.A.
ISIN: FR0000033219
Ticker: EL
Exchange: Euronext Paris
Price (as of August 28, 2026): $93.72 USD on US OTC line and EUR 161.35 on Euronext Paris
Market cap: EUR 75 billion in 2026
Sector / Industry: Healthcare - Healthcare Equipment and Supplies
Index membership: CAC 40
